Keyphrases
Immunocompromised Patients
100%
Interferon Signature
100%
Bronchoalveolar Lavage
100%
Lower Respiratory Tract Infection
100%
Herpesvirus
50%
IFI27
37%
IFITM
37%
Interferon-stimulated Gene 15 (ISG15)
37%
Epstein-Barr Virus
25%
Interferon-α (IFN-α)
25%
Herpesvirus Infection
25%
Infections In Immunocompromised Hosts
25%
Viral Infection
12%
Co-infection
12%
Gene Expression
12%
Immunocompromised Host
12%
Cellular Response
12%
N-group
12%
Six Genes
12%
Immunocompromised Population
12%
Group-based
12%
IFI44L
12%
Continuous Stimulation
12%
Epstein-Barr Virus Reactivation
12%
Siglec
12%
Interferon Pathway
12%
E-Group
12%
RSAD2
12%
Medicine and Dentistry
Interferon
100%
Lung Lavage
100%
Lower Respiratory Tract Infection
100%
Herpesviridae
36%
Epstein Barr Virus
27%
Immunocompromised Patient
18%
Infection in Immunocompromised Patients
18%
Herpes Virus Infection
18%
Virus Infection
9%
Biological Marker
9%
Mixed Infection
9%
Gene Expression
9%
Virus Reactivation
9%
Immunology and Microbiology
interferon
100%
Lower Respiratory Tract
100%
Herpesviridae
54%
Immunocompromised Patient
36%
Epstein Barr Virus
27%
Viral Disease
9%
Coinfection
9%
Gene Expression
9%
Virus Reactivation
9%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Lower Respiratory Tract Infection
100%
Herpesviridae
36%
Immunocompromised Patient
36%
Epstein-Barr Virus
27%
Herpes Virus Infection
18%
Biological Marker
9%
Virus Infection
9%
Mixed Infection
9%
Veterinary Science and Veterinary Medicine
Respiratory Tract Infection
100%